Supraorbital Nerve and Cavernous Sinus Invasion with Poorly Differentiated Carcinoma of Unknown Primary

被引:1
|
作者
Patel, Saagar N. [1 ]
Nakawah, Mohammad Obadah [2 ]
Sadaka, Ama [3 ]
Berry, Shauna [3 ]
Gomez, Juan Ortiz [3 ,4 ]
Powell, Suzanne [3 ]
Lee, Andrew G. [3 ,5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Baylor Coll Med, Sch Med, Houston, TX 77030 USA
[2] Houston Methodist Hosp, Dept Neurol, Houston, TX USA
[3] Houston Methodist Hosp, Blanton Eye Inst, Dept Ophthalmol, Houston, TX USA
[4] Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX USA
[5] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA
[6] Weill Cornell Med, Dept Ophthalmol, New York, NY USA
[7] Weill Cornell Med, Dept Neurol, New York, NY USA
[8] Weill Cornell Med, Dept Neurosurg, New York, NY USA
[9] Univ Texas MD Anderson Canc Ctr, Sect Ophthalmol, Houston, TX 77030 USA
[10] Univ Iowa Hosp & Clin, Dept Ophthalmol, Iowa City, IA 52242 USA
关键词
Carcinoma; perineural invasion; cavernous sinus; supraorbital nerve;
D O I
10.1080/01658107.2017.1401093
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A 50-year-old man presented with a 4-month history of right-sided trigeminal neuropathy in the V1 and V2 distribution, right sixth nerve palsy and Homer syndrome. Magnetic resonance imaging (MRI) showed enhancement and thickening along the right ophthalmic nerve and supraorbital nerve and fullness at the right cavernous sinus extending to Meckel's cave. Evaluation for a primary tumour was negative. Cavernous sinus biopsy showed infiltrating poorly differentiated carcinoma; the patient underwent radiation therapy. To our knowledge this is the only case of poorly differentiated carcinoma involving the supraorbital nerve presenting with trigeminal neuropathy and Homer syndrome in the English ophthalmic literature.
引用
收藏
页码:312 / 315
页数:4
相关论文
共 50 条
  • [31] Primary Intracranial Nerve Sheath Myxoma within the Cavernous Sinus
    Allen, Nichole
    Pearl, Gary
    Wagner, Aaron
    Ramakrishna, Naren
    Health, Orlando
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2018, 77 (06): : 517 - 518
  • [32] Successful Palliation of Poorly Differentiated Thyroid Carcinoma with Direct Invasion into the Sternum
    Tan, Tze-Woei
    Mazzaglia, Peter J.
    Ng, Thomas
    Monchik, Jack M.
    THYROID, 2009, 19 (06) : 663 - 664
  • [33] Poorly Differentiated Neuroendocrine Carcinoma of Unknown Primary Site Presenting as Unexplained Hypoxemia: A Case Report and Literature Review
    Algamdi, Mohmmed
    CHEST, 2015, 148 (04)
  • [34] Carcinoma ex pleomorphic adenoma of soft palate with cavernous sinus invasion
    Chen, Hsuan-Ho
    Lee, Li-Yu
    Chin, Shy-Chyi
    Chen, I-How
    Liao, Chun-Ta
    Huang, Shiang-Fu
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2010, 8
  • [35] Carcinoma ex pleomorphic adenoma of soft palate with cavernous sinus invasion
    Hsuan-Ho Chen
    Li-Yu Lee
    Shy-Chyi Chin
    I-How Chen
    Chun-Ta Liao
    Shiang-Fu Huang
    World Journal of Surgical Oncology, 8
  • [36] The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary
    vanderGaast, A
    Verweij, J
    Planting, AST
    Stoter, G
    HenzenLogmans, SC
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (03) : 181 - 185
  • [37] IMMUNOHISTOLOGICAL STUDIES IN 5 PATIENTS WITH UNKNOWN PRIMARY CARCINOMAS AND POORLY DIFFERENTIATED NEOPLASMS
    GREENBERG, BR
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1989, 19 (03): : 175 - 183
  • [38] METASTASES TO THE CAVERNOUS SINUS FROM PRIMARY-CARCINOMA OF THE LARYNX
    ZAHRA, M
    TEWFIK, HH
    MCCABE, BF
    JOURNAL OF SURGICAL ONCOLOGY, 1986, 31 (01) : 69 - 70
  • [39] POORLY DIFFERENTIATED CARCINOMA OR ADENOCARCINOMA OF UNKNOWN PRIMARY SITE - LONG-TERM RESULTS WITH CISPLATIN-BASED CHEMOTHERAPY
    GRECO, FA
    HAINSWORTH, JD
    SEMINARS IN ONCOLOGY, 1994, 21 (05) : 77 - 82
  • [40] Molecular tumor profiling (MTP) of poorly differentiated neoplasms (PDN) of unknown primary site
    Greco, F. Anthony
    Spigel, David R.
    Hainsworth, John D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)